SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000819050-22-000096
Filing Date
2022-06-09
Accepted
2022-06-09 16:50:33
Documents
13
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A a20220610def-14a.htm DEF 14A 231422
2 bbilogohr2021.jpg GRAPHIC 71984
3 computer.jpg GRAPHIC 3083
4 i2.jpg GRAPHIC 224942
5 i3.jpg GRAPHIC 42660
6 i4.jpg GRAPHIC 354508
7 i5.jpg GRAPHIC 138008
8 i6.jpg GRAPHIC 144912
9 i7.jpg GRAPHIC 41817
10 i8.jpg GRAPHIC 330345
11 ii1.jpg GRAPHIC 149591
12 ml.jpg GRAPHIC 3585
13 tel.jpg GRAPHIC 3575
  Complete submission text file 0000819050-22-000096.txt   2311742
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21088 | Film No.: 221006549
SIC: 2836 Biological Products, (No Diagnostic Substances)